Vimarsana
Biggest News Aggregation in the World

Page 3 - Altimmune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Altimmune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Altimmune Today - Breaking & Trending Today

GSA Capital Partners LLP Grows Stake in Altimmune, Inc. (NASDAQ:ALT) - Vimarsana News

GSA Capital Partners LLP Grows Stake in Altimmune, Inc. (NASDAQ:ALT)

GSA Capital Partners LLP raised its stake in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 153.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 445,868 shares of the company’s stock after purchasing an additional 269,676 shares during the quarter. GSA Capital […]

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - Vimarsana News

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages

NEW YORK, Feb. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities...

NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. - Vimarsana News

NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc.

NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities...

Altimmune (NASDAQ:ALT) Stock Rating Reaffirmed by B. Riley - Vimarsana News

Altimmune (NASDAQ:ALT) Stock Rating Reaffirmed by B. Riley

B. Riley reissued their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $20.00 target price on the stock. A number of other brokerages have also weighed in on ALT. The Goldman Sachs Group started coverage on shares of Altimmune […]

WealthPlan Investment Management LLC Takes Position in Altimmune, Inc. (NASDAQ:ALT) - Vimarsana News

WealthPlan Investment Management LLC Takes Position in Altimmune, Inc. (NASDAQ:ALT)

WealthPlan Investment Management LLC purchased a new position in Altimmune, Inc. (NASDAQ:ALT – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 11,931 shares of the company’s stock, valued at approximately $31,000. A number of other institutional investors and hedge funds also […]